Novel Therapies For Herpes Simplex Virus Infections
$0Z01FY2005AINIH
Niaid Extramural Activities
Investigators
Linked publications & trials
Abstract
We are currently discussing possible new vaccine candidates for therapy of herpes simplex, and planning new clinical trials.Among these is a live, replication-defective HSV-2 vaccine that we showed this past year to be effective in the immunotherapy of genital herpes in the gunea pig model.
View original record on NIH RePORTER →